CSC-012

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameCSC-012
Drug Alias NameCSC-012
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Interleukin-1 receptor accessory protein
TargetsInterleukin-1 receptor accessory protein
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCellerant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCellerant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A